Cite
Hauser G, Blažević I, Salkić N, et al. Erratum to: Diclofenac sodium versus ceftazidime for preventing pancreatitis after endoscopic retrograde cholangiopancreatography: a prospective, randomized, controlled trial. Surg Endosc. 2017;31(2):611doi: 10.1007/s00464-016-5305-z.
Hauser, G., Blažević, I., Salkić, N., Poropat, G., Giljača, V., Bulić, Z., & Štimac, D. (2017). Erratum to: Diclofenac sodium versus ceftazidime for preventing pancreatitis after endoscopic retrograde cholangiopancreatography: a prospective, randomized, controlled trial. Surgical endoscopy, 31(2), 611. https://doi.org/10.1007/s00464-016-5305-z
Hauser, Goran, et al. "Erratum to: Diclofenac sodium versus ceftazidime for preventing pancreatitis after endoscopic retrograde cholangiopancreatography: a prospective, randomized, controlled trial." Surgical endoscopy vol. 31,2 (2017): 611. doi: https://doi.org/10.1007/s00464-016-5305-z
Hauser G, Blažević I, Salkić N, Poropat G, Giljača V, Bulić Z, Štimac D. Erratum to: Diclofenac sodium versus ceftazidime for preventing pancreatitis after endoscopic retrograde cholangiopancreatography: a prospective, randomized, controlled trial. Surg Endosc. 2017 Feb;31(2):611. doi: 10.1007/s00464-016-5305-z. PMID: 27815741.
Copy
Download .nbib